Detalles de la búsqueda
1.
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
Int J Cancer
; 150(2): 279-289, 2022 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34528705
2.
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer.
Breast Cancer Res Treat
; 185(1): 165-173, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32930927
3.
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
Breast Cancer Res Treat
; 189(1): 15-23, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218359
4.
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Support Care Cancer
; 29(1): 311-322, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32358778
5.
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
Breast Cancer Res Treat
; 184(1): 161-172, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789591
6.
Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial.
Cancer
; 124(12): 2552-2560, 2018 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29624641
7.
Estrogen Receptor-Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance.
Oncologist
; 23(5): 528-539, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29352052
8.
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.
Breast Cancer Res Treat
; 171(2): 325-334, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29789969
9.
Checkpoint Inhibitors in the Treatment of Breast Cancer.
Curr Oncol Rep
; 20(7): 51, 2018 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29713831
10.
Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.
Cancer
; 123(1): 131-137, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27526056
11.
Sexual health needs and educational intervention preferences for women with cancer.
Breast Cancer Res Treat
; 165(1): 77-84, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28547655
12.
Genetic predisposition to bevacizumab-induced hypertension.
Gynecol Oncol
; 147(3): 621-625, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28969913
13.
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
JAMA
; 318(9): 825-835, 2017 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28873162
14.
Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.
Cancer
; 122(8): 1178-84, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26859126
15.
The Role of CDK4/6 Inhibition in Breast Cancer.
Oncologist
; 20(5): 483-90, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25876993
16.
Cancer-related internet information communication between oncologists and patients with breast cancer: a qualitative study.
Psychooncology
; 24(11): 1439-47, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25631285
17.
Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?
Breast J
; 21(5): 514-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26271749
18.
Endocrine therapy for advanced breast cancer.
Clin Adv Hematol Oncol
; 12(4): 214-23, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25003351
19.
Alopecia with endocrine therapies in patients with cancer.
Oncologist
; 18(10): 1126-34, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24037977
20.
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.
Clin Cancer Res
; 29(15): 2781-2790, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261814